AlloVir

$23.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.20 (-4.92%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AlloVir and other stocks, options, and ETFs commission-free!

About ALVR

AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

CEO
David L. Hallal
Employees
53
Headquarters
Houston, Texas
Founded
2013
Market Cap
1.43B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
338.86K
High Today
$24.40
Low Today
$23.00
Open Price
$24.25
Volume
397.31K
52 Week High
$48.96
52 Week Low
$18.15

ALVR Earnings

-$4.43
-$2.95
-$1.48
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, Pre-Market

You May Also Like

AGFY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure